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Abstract  The  recent  application  of  endovascular  treatment  techniques  to  venous  pathologies
has meant  that  new  therapeutic  solutions  can  be  offered  to  patients  suffering  from  post-
thrombotic  syndrome.  This  often-underestimated  condition  frequently  complicates  cases  of
deep vein  thrombosis,  whether  treated  or  not,  leading  to  a  chronic  and  disabling  set  of  clini-
cal symptoms  (oedema,  claudication,  pain,  venous  ulcers,  etc.)  due  to  the  combination  of  the
pathophysiological  phenomena  of  obstructions  and  reﬂux.  These  clinical  signs  see  only  minimal
improvement  when  managed  with  the  classic  medical  treatment,  venotonic  agents,  and  venous
compression.  We  report  the  cases  of  two  patients  suffering  with  chronic  post-thrombotic  venous
obstruction  of  the  lower  limbs  in  whom  endovascular  treatment  brought  clear  and  long-lasting
clinical improvement.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Post-thrombotic  syndrome  (PTS)  is  a  common  complication  of  deep  vein  thrombosis  in
spite  of  widespread  usage  of  anticoagulants.  One  patient  out  of  every  two  or  three  will
develop  it  after  having  had  deep  vein  thrombosis  (DVT)  treated  with  anticoagulants  [1].
Two  clinical  forms  have  been  described.  The  ﬁrst  and  less  serious  form  presents  as  venous
stasis,  with  varicose  veins,  oedema,  depigmentation,  heavy  and  ‘‘restless’’  legs;  the
second  and  more  serious  form  involves  signiﬁcant  pain,  chronic  oedema  and  ulcers  [2].
PTS  has  a  major  impact  on  patients’  quality  of  life  as  well  as  signiﬁcant  medical,  eco-
nomic  and  social  consequences  in  terms  of  care  and  cessation  of  work  [3].  The  clinical
symptomatology  reported  is  categorised  into  seven  stages  depending  on  the  seriousness
∗ Corresponding author.
E-mail address: olivier.pellerin@egp.aphp.fr (O. Pellerin).
211-5684/$ — see front matter © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
oi:10.1016/j.diii.2012.03.003
Endovascular  treatment  for  post-thrombotic  syndrome  
Table  1  Clinical,  etiological,  anatomical  and  patho-
physiological  (CEAP)  classiﬁcation  of  post-thrombotic
syndrome  following  Eklöf  et  al.  [4].
C:  Clinical  presentationa
0 No visible  or  palpable  vein  abnormality
1 Telangiectasias  or  reticular  veins
2  Varicose  veins.  These  can  be  distinguished  from
reticular  veins  because  their  diameter  ≥  3  mm
3  Oedema
4  Skin  changes
C4a:  pigmentation  and/or  eczema
C4b:  lipodermatosclerosis  and/or  white  atrophy
5 Healed  ulceration
6 Non-healed  ulceration
E:  Etiology
C C  for  congenital
P  P  for  primary
S  S  for  secondary
N  N  for  not  known
A:  Anatomical  location
S S for  superﬁcial
D D for  deep
P P for  perforating
N N for  no  venous  localisation  identiﬁed
P:  Causal  pathophysiology
R  R  for  reﬂux
O  O  for  obstruction
RO  RO  for  reﬂux  and  obstruction
N  N  for  no  identiﬁable  venous  pathophysiology
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iEach class must be followed by: A: for asymptomatic; S: for
symptomatic (pain, pruritis, heavy legs, cramps).
of  the  symptoms  (Table  1)  [4].  The  pathophysiology  of  PTS
concerns  the  combination  of  two  phenomena:
• deterioration  of  the  intima,  valve  incompetence  and  com-
promised  calf  muscle  pump  function,  leading  to  chronic
reﬂux;
• persistent  chronic  proximal  venous  obstruction  (iliac
veins,  common  femoral  vein),  due  to  patency  of  the
proximal  vein  being  incompletely  re-established  [5].  This
results  in  serious  cases  of  PTS  [6].
We  report  here  the  endovascular  technique  used  and  the
clinical  outcome  in  two  case  studies  of  patients  with  serious
PTS.
Case 1
A  50-year-old  female  was  seen  for  diagnostic  and  thera-
peutic  management  of  a  chronic  oedema  of  the  left  lower
limb,  which  had  suddenly  worsened  and  become  painful.
The  main  feature  of  her  medical  history  was  a  left  DVT  10
years  previously.  This  chronic  thrombosis  had  caused  dis-
abling  symptoms  but  the  patient  had  not  acted  on  them
and  so  her  doctor  had  not  had  the  opportunity  to  refer
her  to  a  specialised  centre.  This  presentation  of  PTS  is
classed  as  C3s,  Es,  Ad,  Po  according  to  the  Clinical,  etiologi-
cal,  anatomical  and  pathophysiological  (CEAP)  classiﬁcation
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4].  Explorations  (Doppler  ultrasonography,  pulmonary  and
enous  CT  angiography)  revealed  a  recent  thrombosis  of  the
eft  external  iliac  vein  with  a  ﬁbrous  occlusion  of  the  com-
on  iliac  vein.  The  results  of  coagulation  investigations  to
heck  for  thrombophilia  were  normal.  In  spite  of  15  days  of
nticoagulant  treatment  that  the  patient  adhered  to  well,
his  painful  oedema  of  the  left  lower  limb  persisted  (the
iameter  of  the  thigh  was  36  cm  on  the  right  compared  to
1.5  cm  on  the  left).  A  repeat  Doppler  ultrasound  scan  was
arried  out  in  view  of  the  absence  of  any  favourable  clin-
cal  progress.  This  showed  that  the  occlusion  persisted  in
he  left  common  iliac  vein.  In  view  of  this  persistent  and
yperalgic  chronic  occlusion  of  the  left  common  iliac  vein,
ndovascular  revascularisation  was  carried  out  using  the
echnique  described  below.  Firstly,  a  5F  introducer  sheath
as  placed  in  the  left  common  femoral  vein  under  ultra-
ound  guidance.  Venography  performed  through  the  sheath.
t  conﬁrmed  the  presence  of  the  left  common  iliac  vein
cclusion.  And  allowed  the  area  and  extent  of  the  obstruc-
ion  to  be  localised.  The  venography  also  showed  that
hrombi  were  present  (Fig.  1).  In  order  to  protect  against
ulmonary  embolism  during  the  recanalisation  procedure,
 retrievable  vena  cava  ﬁlter  (ALN® Implant  Chirugicaux,
hisconaccia,  France)  was  placed  in  the  inferior  vena  cava
below  the  renal  veins),  by  a  jugular  access.  Under  effective
nti-coagulation  (Heparin  2.000  IU),  recanalisation  of  the
cclusion  was  carried  out  using  a  straight  0.035′ hydrophilic
uidewire.  This  guidewire  was  manipulated  through  a  5F
ertebral  catheter.  The  occlusion  was  easily  crossed.  The
ngioplasty  was  conducted  using  a  balloon  8  mm  in  diam-
ter  and  40  mm  long.  When  the  balloon  was  inﬂated,  two
ocal  areas  of  severe  stenosis  were  revealed,  situated  in  the
ommon  iliac  and  external  iliac  veins.  Repeat  venography
urther  to  angioplasty  showed  the  venous  system  to  have  a
triated  appearance  together  with  the  presence  of  numer-
us  endoluminal  thrombi,  and  a  moderate  recoil.  Note:  BTW
n  french  the  curent  term  used  is  ‘‘retour  elastique’’  and
n  english  recoil.  A  10  mm  ×  60  mm  self-expandebale  stent
as  placed  over  the  residual  stenoses.  Manual  thromboaspi-
ation  was  carried  out  to  extract  the  remaining  thrombi.
he  ﬁnal  venography  conﬁrmed  that  the  veins  treated  were
atent.  Straight  after  the  procedure  the  patient  was  started
n  dual  anti-platelet  aggregation  therapy  with  clopidogrel
nd  aspirin,  prescribed  for  a  1-month  duration.  Oral  anti-
oagulant  therapy  was  prescribed  for  a  3-month  duration.
he  vascular  medicine  team  planned  to  consider  whether
o  prolong  anticoagulant  therapy  after  the  third  month  of
onitoring.  The  vena  cava  ﬁlter  was  removed  successfully
 weeks  after  the  procedure.  This  time,  angiography  of  the
ena  cava  conducted  prior  to  extraction  of  the  ﬁlter  con-
rmed  that  the  iliac  and  femoral  veins  were  patent  without
urther  stenosis  (Fig.  2).  The  clinical  symptomatology  was
een  to  resolve  within  ten  days.  Six  months  after  the  inter-
ention,  the  symptoms  had  completely  disappeared  and  a
oppler  ultrasound  conﬁrmed  that  the  external  and  common
liac  veins  and  the  common  femoral  vein  were  patent.ase 2
 66-year-old  male  had  a  5-year  history  of  recurrent  DVT
f  the  right  lower  limb.  During  the  most  recent  episode,
382  O.  Pellerin  et  al.
Figure 1. Initial left femoral venogram with (a) and without (b) digital subtraction. This injection into the left common femoral vein
conﬁrms the occlusion of the primary iliac vein, reveals the presence of a venous network secondary to venous hypertension (arrows) and
opaciﬁcation of the collateral veins draining via pelvic anastomoses.
Figure 2. Final left femoral venogram with (a) and without (b) digital subtraction after recanalisation, angioplasty and stenting of
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wo residual stenoses (in the external iliac and common femoral v
ypertension (pelvic collateral veins, iliac venous network) have di
ight  iliofemoral  thrombosis  had  been  complicated  by  PTS
nvolving  signiﬁcant  oedema  of  the  lower  limb  and  venous
lcers.  The  ulcers  took  several  months  to  heal,  and  the
edema  persisted.  Although  the  patient  was  on  long-term
nticoagulant  therapy,  as  well  as  class  III  venous  compres-
ion,  the  oedema  remained  disabling.  This  presentation  of
TS  is  classed  as  C5s,  Es,  Ad,  Po  according  to  the  CEAP  clas-
iﬁcation  [4].  Thrombophilia  investigations  did  not  reveal
ny  abnormalities.  A  Doppler  ultrasound  scan  of  the  veins
howed  complete  and  chronic  occlusion  of  the  right  exter-
al  iliac  vein,  and  chronic  partial  occlusion  of  the  common
emoral  vein  and  superﬁcial  femoral  vein.  Venography  was
arried  out  via  a  venous  puncture  in  the  back  of  the  right  foot
nd  revealed  multiple  chronic  venous  occlusions  in  the  right
xternal  iliac  vein  and  common  iliac  vein  as  well  as  steno-
is  of  the  common  femoral  vein.  Numerous  collateral  veins
nastomosed  with  the  pelvic  venous  system  were  draining
he  right  lower  leg  via  the  left  iliac  and  common  femoral
eins  (Fig.  3).  Retrograde  access  for  the  endovascular  inter-
ention  was  gained  through  the  right  and  left  common
emoral  veins.  This  allowed  catheterisation  of  the  common
emoral  vein  stenosis  and,  using  the  crossover  technique,
D
T
nram conﬁrms that the proximal vessels have reopened. Note that
) remain detectable (arrows). Elsewhere, indirect signs of venous
ared.
he  iliac  occlusion  could  be  passed.  In  a  the  same  way  as  in
ur  ﬁrst  clinical  case,  an  angioplasty  was  carried  out  using  an
 mm/40  mm  balloon  in  the  common  femoral  vein,  followed
y  angioplasty  using  a  9  mm/40  mm  balloon  for  the  occlusion
f  the  iliac  veins.  The  recoil  of  the  external  iliac  and  com-
on  femoral  veins  required  a  10  mm/60  mm  self-expanding
tent.  The  ﬁnal  venography  showed  the  femoral  and  iliac
eins  to  be  fully  patent.  Furthermore,  none  of  the  pelvic  col-
ateral  veins  could  now  be  visualised  (Fig.  4).  Straight  after
he  procedure  the  patient  was  started  on  dual  anti-platelet
ggregation  therapy  (clopidogrel  and  aspirin),  prescribed
or  a  1-month  duration,  together  with  oral  anticoagulants.
he  clinical  symptomatology  resolved  within  ﬁve  days.  Six
onths  after  the  intervention,  the  oedemas  had  resolved
nd  the  patient  did  not  report  that  the  venous  ulcers  had
eturned.  A  Doppler  ultrasound  conﬁrmed  that  all  of  the
ecanalised  vessels  were  patent.iscussion
he  two  clinical  cases  presented  above  illustrate  the  tech-
ical  feasibility  of  recanalisation  of  proximal  veins  and  the
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Figure 3. Initial right femoral venogram with (a) and without (b) digital subtraction. The venogram images show right iliofemoral long
segment stenosis (arrows). There is signiﬁcant opaciﬁcation of the pelvic collateral veins creating anastomoses with the left femoroiliac
network.
Figure 4. Venography after angioplasty focusing on the right iliac stenosis with (a) and without (b) digital subtraction. The images show
haemodynamically signiﬁcant elastic return (arrow) (reﬂux in the internal iliac vein and in the pelvic collateral veins). The iliac vein shows
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Cthe usual striated appearance of a previously thrombosed and recent
reopening of the iliac vessel maintained by a stent.
clinical  beneﬁts  that  it  can  offer  patients  with  PTS.  The
collateral  veins  linking  to  the  pelvic  system  and  their  subse-
quent  disappearance  seen  in  the  second  case  are  evidence
that  low-pressure  venous  ﬂow  had  been  restored.  This  is
evidence  that  the  intervention,  which  offers  an  instant
improvement  in  symptoms,  is  haemodynamically  effective.
This  principle  is  based  on  a  percutaneous  approach  to  the
proximal  venous  system  using  common  femoral  access.  The
techniques  used  for  recanalisation,  angioplasty  and  stent
implantation  are  the  same  as  those  applied  in  the  arterial
system.There  are  currently  no  publications  that  provide  level
A  or  B  evidence,  but  a  number  of  studies  providing  level
C  evidence.  These  studies  report  technical  success  rates
of  90  to  98%.  Primary  patency  after  1  and  4  years  ranges
r
T
i
ranalised vessel. The venogram presented in Fig. 4c shows complete
rom  50  to  83%.  Secondary  patency  after  1  and  5  years  is  81
nd  93%  respectively  [7—10]. Complications  are  rare  (<  6%).
hen  they  do  arise,  they  usually  concern  early  rethrombosis
f  the  revascularised  vessel  and  minor  haematomas  at  the
uncture  site.  There  has  been  no  report  of  serious  haemor-
hage  in  spite  of  the  use  of  dual  anti-platelet  aggregation
herapy  combined  with  anticoagulants  [7—10]. The  authors
eport  a  strong  correlation  between  patency  and  resolution
f  symptoms.  The  indication  for  revascularisation  applies
o  patients  with  stage  C3  and  higher  PTS  according  to  the
EAP  classiﬁcation  (Table  1)  [11]. However,  although  the
esults  are  remarkable  some  questions  remain  unanswered.
here  has  been  no  published  article  that  satisfactorily  stud-
es  the  possibility  of  venous  reﬂux  arising  or  worsening  after
ecanalisation.
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From  a  technical  point  of  view,  recanalisation  may  be  car-
ied  out  ipsi-  and/or  contralaterally.  An  angioplasty  alone
s  rarely  sufﬁcient,  because  in  a  system  with  low  pres-
ure  and  low  ﬂow  it  is  essential  that  a  perfect  result  in
erms  of  morphology  is  achieved.  The  slightest  vessel  wall
amage  or  change  in  pressure  gradient  will  cause  immedi-
te  re-obstruction.  This  is  why  long  self-expendable  stents
ith  a  large  diameter  are  required  to  treat  these  patients.
lthough  there  is  no  consensus  on  the  use  of  a  retrievable
ena  cava  ﬁlter  to  protect  against  pulmonary  embolism  dur-
ng  recanalisation  of  chronically  occluded  proximal  veins.
heir  use  for  preventive  purposes  seems  to  be  justiﬁed.
’Sullivan  recommends  using  them  in  patients  with  pul-
onary  hypertension,  right  ventricle  dysfunction,  and  a
ecent  history  of  pulmonary  embolism  or  venous  thrombosis
uring  procedures  to  revascularise  chronic  or  acute  venous
cclusions  [12].
Triple anti-thrombotic  therapy  combining  aspirin,  clopi-
ogrel  and  an  anticoagulant  is  usually  prescribed  in  order  to
revent  rethrombosis  [12,13].  Justiﬁcation  for  this  approach
s  based  only  on  opinion  and  analogies  with  the  treatments
rescribed  after  coronary  artery  stenting.  Currently  there
s  no  established  consensus  on  the  safety  and  efﬁcacy  of
his  combination  of  anti-platelet  drugs  and  an  anticoagulant
n  patients  who  have  received  a  venous  stent.  This  pres-
ription  is,  however,  commonly  given  for  a  3-month  period
12,13].  Anti-platelet  aggregants  have  not  been  proved  to
e  effective  in  the  treatment  of  DVT.  Anticoagulants  remain
he  reference  therapy  for  DVT  and  pulmonary  embolism
n  the  acute  phase.  Ruiz-Gimenez  et  al.  assessed  the  risk
f  complications  of  haemorrhage  due  to  anticoagulants  in
he  speciﬁc  context  of  DVT/PE  to  be  0.1%,  2.8%,  and  6.2%,
n  low-,  medium-  and  high-risk  patients  respectively.  This
riple  anti-thrombotic  therapy  represents  a  potential  risk  of
aemorrhage,  and  must  be  subject  to  both  a  rigorous  assess-
ent  of  the  risk/beneﬁt  balance  for  patients  when  they  are
elected  and  very  close  monitoring.
A  number  of  radiological  investigations  are  required  in
rder  to  propose  this  indication  and  consider  this  revascu-
arisation  technique.  Doppler  ultrasound  is  the  ﬁrst  step  for
creening  patients.  It  can  detect  the  pathology  of  reﬂux  and
ocate  the  occluded  area,  identify  the  direction  of  venous
ow,  and  the  possible  routes  of  derivation.  CT  angiography
nd  MRI  angiography  capture  morphological  information  on
he  localisation  and  extent  of  the  occlusion.  In  any  case,  as
oon  as  the  presence  of  a  proximal  obstacle  is  conﬁrmed,
esion  anatomy  will  be  conﬁrmed  by  venography.  It  is  imme-
iately  followed  by  recanalisation.  Comparable  reports  have
een  made  in  the  management  of  proximal  occlusions  of  the
pper  limbs  [14].
PTS  is  caused  by  the  development  of  venous  hyperten-
ion.  This  is  secondary  to  the  existence  of  chronic  venous
eﬂux  secondary  to  the  loss  of  normal  valve  function.  The
resence  of  a  proximal  venous  obstruction  is  the  cause  of
erious  clinical  forms  of  PTS.  It  is  prolonged  persistence  of
ypertension  in  the  deep  venous  system  that  causes  valve
unction  to  deteriorate  in  the  perforating  veins,  resulting  in
he  direct  transmission  of  venous  hypertension  (especially
n  standing  and  walking)  to  the  superﬁcial  venous  system.
rogressively,  there  is  a  resulting  increase  in  endothe-
ial  permeability.  This  excessive  permeability  means  that
ater,  macromolecules  and  granulocytes  can  pass  from  theO.  Pellerin  et  al.
ascular  space  to  the  interstitium.  This  passage  of  water
auses  oedema,  the  presence  of  free  radicals  and  prote-
lytic  enzymes,  and  has  been  suggested  to  be  the  cause  of
lcers  developing  [15—17]. Reﬂux  in  the  proximal  veins  is
ecognised  as  being  a  crucial  feature  for  the  development  of
TS.  The  presence  of  severe  proximal  stenosis  or  a  proximal
cclusion  is  a  major  aggravating  factor  [6,18,19].  Proximal
VTs  (common  femoral  and/or  iliac  veins)  are  major  predic-
ive  risk  factors  for  developing  PTS  [19,20]. Other  factors
uch  as  a  history  of  ipsilateral  DVT,  age  more  than  60  years,
besity,  and  varicose  veins  are  also  predictive  for  develop-
ng  PTS  [19,21].  If  oral  anticoagulant  therapy  prescribed  for
cute  DVT  is  unsuccessful,  this  is  associated  with  a  high  risk
f  developing  PTS  [22,23]. Equally,  adhering  to  the  antico-
gulant  treatment  regimen  and  duration  reduces  the  risk  of
eveloping  PTS  [19,21].  Although  the  cornerstone  of  symp-
omatic  treatment  is  elastic  venous  compression,  adherence
s  difﬁcult  [24]. In  2003  Kahn  et  al.  [25]  published  the  results
f  a  satisfaction  survey  of  patients  with  PTS.  It  appears  that
lastic  venous  compression  stockings  and  physical  exercise
re  effective  for  the  relief  of  symptoms,  but  their  use  is
estrictive  and  uncomfortable  and  only  20  to  30%  of  patients
ollow  this  treatment  [23,24].
The  endovascular  management  of  disabling  cases  of  post-
hrombotic  syndrome  is  feasible,  and  remarkably  clinically
ffective.  Today,  it  seems  that  awareness  of  this  technique
nd  its  results  needs  raised  among  the  clinicians  managing
hese  patients  as  well  as  among  radiologists.
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